NEW ORLEANS – Current research supports the notion that lifestyle choices influence cardiovascular health, but to what extent specific emotions play is undefined. Now, new research from the University of Pennsylvania School of Medicine has revealed the role that guilt may play as a motivational tool for cardiovascular patients.
Penn researchers interviewed 100 adult cardiology outpatients about the role that guilt plays in their adherence to instructions given by their physicians and as part of their views of their own health. The majority of the patients reported that guilt provides motivation to make lifestyle changes; this finding was associated with having children but no other demographics. When asked whether providers should routinely address guilt with their patients, over half of the patients said yes. Patients with a religious affiliation were more likely to answer that health practitioners should routinely address guilt.
Of the entire sample, 66 percent of patients had experienced a major cardiovascular event, such as a heart attack. Just over 20 percent of these patients reported feelings of guilt related to their health. However, half of these patients wished they had taken better care of themselves, but had no feelings of guilt relating to their health. The study results were reported at the 2011 American College of Cardiology meeting in New Orleans.
“When counseling cardiovascular patients about lifestyle, practitioners should consider addressing guilt as both a motivation for, and a barrier to, lifestyle change, particularly in patients with religious backgrounds,” concluded senior author James Kirkpatrick, MD, assistant professor of Medicine, Cardiovascular Medicine Division at Penn. “Further research is needed to explore the impact of guilt motivation on patient outcomes.”
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.